Overview of WHO Public Assessment Report (WHOPAR)

  HA434 - Lopinavir/Ritonavir - 100mg/25mg - Film-coated tablets - Abbott GmbH & Co. KG - GERMANY

• Part 1

• Part 2a

• Part 7

Part 1 – Abstract
Part 2a – All accepted Presentations
Part 2b – Visual appearance of the product
Part 3 – Product Information Leaflet
Part 4 – Summary of Product Characteristics
Part 5 – Label
Part 6 – Discussion
Part 7 – Steps before Prequalification
Part 8 – Steps following Prequalification